After a loss of $6.8 million in the second quarter of 2012, InSite Vision has reported a net income of $12.1 million for the second quarter of 2013, according to a company news release.The increase is largely attributable to InSite’s sale of royalty rights to Besivance (besifloxacin ophthalmic suspension 0.6%) for $15 million.
BLOG: Dry eye symptoms vs. signs: When to treat
Let’s talk a little philosophy, shall we?There are two distinct parts to the question “When should you treat dry eye?” The first one is a practice style question and the other one is a style of practice one.
Macular hole closure with ILM peeling linked to progressive macular thinning
Macular hole closure with internal limiting membrane peeling resulted in progressive macular thinning up to 2 years after surgery, according to a study.The prospective, interventional case study included 24 eyes of 24 patients with a mean age of 65.5 y…
Aging Is Not a Disease: Distinguishing Age-Related Macular Degeneration from Aging
Publication date: Available online 9 August 2013
Source:Progress in Retinal and Eye Research
Author(s): Daniel Ardeljan , Chi-Chao Chan
Age-related macular degeneration (AMD) is a disease of the outer retina, characterized most significantly by atrophy of photoreceptors and retinal pigment epithelium accompanied with or without choroidal neovascularization. Development of (Read more...)
Research findings offer clues to the origin of retinal disorders later in life
Scientists are developing a clearer picture of how visual systems develop in mammals. The findings offer important clues to the origin of retinal disorders later in life.
The global atlas of trachoma: an important tool in the fight against infectious blindness
An estimated 129.4 million people live in areas of Africa where blinding trachoma is confirmed to occur, according to a paper publishing August 8 in PLOS Neglected Tropical Diseases. The distribution of the disease varies greatly across the continent, …